Oncotype DX TM predicts benefit from adjuvant chemotherapy in women with early breast cancer at intermediate risk of distant recurrence. Issue 5 (May 2017) - Harvey, Kate; Levitt, Nicky; Phillips, Ben; Roy, Pankaj